Cargando…
Current Status of Endolysin-Based Treatments against Gram-Negative Bacteria
The prevalence of multidrug-resistant Gram-negative bacteria is a public health concern. Bacteriophages and bacteriophage-derived lytic enzymes have been studied in response to the emergence of multidrug-resistant bacteria. The availability of tRNAs and endolysin toxicity during recombinant protein...
Autores principales: | Gontijo, Marco Túlio Pardini, Jorge, Genesy Perez, Brocchi, Marcelo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8532960/ https://www.ncbi.nlm.nih.gov/pubmed/34680724 http://dx.doi.org/10.3390/antibiotics10101143 |
Ejemplares similares
-
EbfC/YbaB: A Widely Distributed Nucleoid-Associated Protein in Prokaryotes
por: Cordeiro, Tamires Fernanda Vilas Boas, et al.
Publicado: (2022) -
Characterization of Three Different Endolysins Effective against Gram-Negative Bacteria
por: Jeong, Tae-Hwan, et al.
Publicado: (2023) -
Bacillus phage endolysin, lys46, bactericidal properties against Gram-negative bacteria
por: Sarjoughian, Mohammad Reza, et al.
Publicado: (2020) -
Les misérables: a Parallel Between Antimicrobial Resistance and COVID-19 in Underdeveloped and Developing Countries
por: Pérez Jorge, Genesy, et al.
Publicado: (2022) -
Correction to: Les misérables: A Parallel Between Antimicrobial Resistance and COVID‑19 in Underdeveloped and Developing Countries
por: Jorge, Genesy Pérez, et al.
Publicado: (2022)